SLC6A3 and Parkinson disease: Repeated L-DOPA injections induced marked expression of DAT and apparent DA-immunoreactivity in GFAP-positive reactive astrocytes on the lesioned side of the striatum in hemi-PD rats (Figs. 4 and 5).